Abzena
Austin McKinsey has a robust background in bioconjugation and advanced therapies, currently serving as the Manager of PD Bioconjugation at Abzena since August 2020, following roles as a Senior Bioconjugation Scientist and Bioconjugation Scientist. Previously, Austin was an Associate Scientist and Manufacturing Associate II at WuXi Advanced Therapies from August 2017 to August 2020. Austin holds a Bachelor of Science degree in Pharmacology and Toxicology from the University of the Sciences in Philadelphia.
This person is not in any offices
Abzena
1 followers
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.